Oral Ifetroban to Treat Aspirin Exacerbated Respiratory Disease (AERD)

Summary

The purpose of this phase 2 study is to assess the safety and efficacy of oral ifetroban for the treatment of aspirin-exacerbated respiratory disease (AERD). AERD is a disease that involves asthma, recurring nasal polyps, and respiratory reactions to aspirin and other nonsteroidal anti-inflammatory drugs.

Timeline

Start

2017-07-17

Primary completion

2023-04-25

Completion

2023-04-25

Drugs

Indications